The Department of War has stated they will only contract with AI companies who accede to “any lawful use” and remove safeguards in the cases mentioned above. They have threatened to remove us from their systems if we maintain these safeguards; they have also threatened to designate us a “supply chain risk”—a label reserved for US adversaries, never before applied to an American company—and to invoke the Defense Production Act to force the safeguards’ removal. These latter two threats are inherently contradictory: one labels us a security risk; the other labels Claude as essential to national security.
但这种垄断格局，即将被打破，多款在研新药正从作用机制到给药方式，向Vosoritide发起挑战。Ascendis的TransCon-CNP通过包裹技术延长了药物作用时间，实现了周剂给药，目前正处于FDA审批阶段；而BridgeBio的口服药Infigratinib，则从作用机制到用药体验实现全面突破。
Tony Jolliffe/ BBC News，详情可参考谷歌浏览器【最新下载地址】
Why am I writing this today?
。关于这个话题，同城约会提供了深入分析
�@�G���^�[�v���C�Y������Kiro�̊g���@�\���Ǘ��ł����A�g���@�\���W�X�g���K�o�i���X�@�\�́AKiro���Г��p�̊g���@�\���W�X�g���Ɍ����邱�ƂŁA�Г��ŏ��F���ꂽ�g���@�\�����𗘗p�\�ɂł����A�Ƃ������̂ł��B。关于这个话题，Line官方版本下载提供了深入分析
businessinsider.com